Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fresenius Kabi España is the Spanish subsidiary of the global healthcare leader Fresenius Kabi, specializing in essential medicines and technologies for infusion, transfusion, and clinical nutrition. The company provides a comprehensive portfolio of products including intravenous generic drugs, infusion therapies, and medical devices designed for the care of critically and chronically ill patients. In Spain, the company maintains a significant industrial presence with a major manufacturing plant in Vilassar de Dalt, which produces a variety of pharmaceutical forms for both domestic and international markets. Beyond its traditional core business, Fresenius Kabi España is actively expanding its footprint in the biosimilars market, focusing on high-quality treatments for oncology and autoimmune diseases. Their services extend to homecare through specialized support for patients requiring complex nutritional or infusion treatments outside the hospital setting.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fresenius Kabi España.